Recent Updates
Recently added Catalysts
RLAY Positive Sentiment

Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023

Thursday, October 26, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Relay Therapeutics, a clinical-stage precision medicine company, will announce its third quarter 2023 financial results and corporate highlights on November 2, 2023. This announcement is set to take place after the U.S. financial markets close. Such reports typically provide insights into the company's performance and future strategies.
Price reaction · baseline $6.01 (2023-10-25 close) · hit after-hours · clean, no other RLAY news in the window
day 0 close
+5.3%
day 1
+0.8%
day 3 · peak
+9.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Relay Therapeutics is reporting its financial results, indicating potential growth.
  • The announcement includes corporate highlights, signaling transparency and shareholder communication.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+284%
120-day peak, hindsight
Typical move
11.8%
average across 6 past catalysts
Cash runway
~50 mo
Minimal dilution risk
Lead asset
RLY-8161
Phase 1 · Advanced NRAS-Mutant Melanoma

Full Press Release Details

CAMBRIDGE, Mass., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report third quarter 2023 financial results and corporate highlights after the U.S. financial markets close on Thursday, November 2, 2023.
About Relay Therapeutics

Frequently Asked Questions

When will Relay Therapeutics report Q3 2023 financial results?

Relay Therapeutics will report its Q3 2023 financial results on November 2, 2023.

What is Relay Therapeutics focused on?

Relay Therapeutics specializes in precision medicine and drug discovery technologies.

Where is Relay Therapeutics located?

Relay Therapeutics is based in Cambridge, Massachusetts.

What markets will be affected by the report?

The financial report will be released after U.S. markets close.

ShareAdd on Google
Tags: RLAY Viatris Investor Conferences Healthcare Relay Therapeutics financial results corporate highlights Q3 2023
Last updated: Oct 26, 2023

Biotech snapshot

Cash runway
$911M liquidity · $18M/mo burn
~50 mo
Minimal dilution risk
Lead asset
RLY-8161Phase 1
Advanced NRAS-Mutant Melanoma →

Catalyst track record

+284%
best trade around RLAY's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for RLAY.

See every catalyst's timing & PoA →